Vascular endothelial growth factor gene-transferred bone marrow stromal cells engineered with a herpes simplex virus type 1 vector can improve neurological deficits and reduce infarction volume in rat brain ischemia - Commentary

Research output: Contribution to journalComment/debatepeer-review

Original languageEnglish (US)
Pages (from-to)594
Number of pages1
JournalNeurosurgery
Volume61
Issue number3
DOIs
StatePublished - Sep 2007

ASJC Scopus subject areas

  • Surgery
  • Clinical Neurology

Cite this